Top suggestions for poster Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe PlaquePsoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials
Explore more searches like poster Durability of Response With Icotrokinra, a Targeted Oral Peptide, in Adults With Moderate-to-Severe PlaquePsoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials